stars 1 stars 2 stars 3

Orbus Therapeutics Inc. is a late-stage, private biopharmaceutical company that is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The Company's lead product candidate, eflornithine, is being evaluated in a pivotal Phase 3 clinical trial in patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer.

Orbus Therapeutics, Inc. Questions

The Orbus Therapeutics, Inc. annual revenue was $5 million in 2026.

Noymi Yam is the VP, Chief Scientific Officer of Orbus Therapeutics, Inc..

3 people are employed at Orbus Therapeutics, Inc..

Orbus Therapeutics, Inc. is based in Palo Alto, California.

The NAICS codes for Orbus Therapeutics, Inc. are [541714, 541, 5417, 54, 54171].

The SIC codes for Orbus Therapeutics, Inc. are [87, 873].

Top Orbus Therapeutics, Inc. Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Winter 2026 G2 Leader Mid Market Winter 2026 G2 Leader Small Business Winter 2026 G2 Most Implementable Winter 2026 G2 Best Est ROI Mid Market Winter 2026 G2 Leader Momentum Winter 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users